Greenphire Enhances Patient Convenience Solutions, Supporting Clinical Trial Sites with Recruitment and Retention Worldwide
Company Executives, Clinical Trial Site, and Patient Advocate to Address Digital Innovation's Role in Patient Retention in Upcoming SCRS Webinar
News provided by
Share this article
KING OF PRUSSIA, Pa., May 4, 2021 /PRNewswire/ --
Greenphire, the global leader in financial lifecycle management for clinical trials, today announced sharp growth of its patient convenience solutions, ClinCard and ConneX, worldwide. The company, which now serves investigator sites in more than 70 countries, also made strategic enhancements to its solutions that support adoption, training, and usage of technologies.
®, the trusted participant travel service designed to eliminate logistical barriers to participation in global clinical trials, has now facilitated travel in 34 countries, with the ability to arrange travel and accommodations worldwide. Notably, after going live with in-country support in China, Greenphire has already executed more than 200 patient itineraries. In addition, the number of studies using ConneX increased by 62% and the number of itineraries by 40% since the start of 2020, with notable increases in France and Russia.